Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage
Journal of Tissue Engineering and Regenerative Medicine · 2022-06 · 16 (6) · 550-558
DOI: 10.1002/term.3299 ↗At a glance
Journal article in Journal of Tissue Engineering and Regenerative Medicine, published online on 2022-03-23. Written by Seo Rin Kim and 8 co-authors. Institution: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA. Major MEDLINE topics: Mesenchymal Stem Cells, Renal Artery Obstruction. Cited 15 times so far (Crossref); 30 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NIA NIH HHS, National Institutes of Health.
Abstract (original language)
Chronic ischemia triggers senescence in renal tubules and at least partly mediates kidney dysfunction and damage through a p16Ink4a -related mechanism. We previously showed that mesenchymal stromal/stem cells (MSCs) delivered systemically do not effectively decrease cellular senescence in stenotic murine kidneys. We hypothesized that selective MSC targeting to injured kidneys using an anti-KIM1 antibody (KIM-MSC) coating would enhance their ability to abrogate cellular senescence in murine renal artery stenosis (RAS). KIM-MSC were injected into transgenic INK-ATTAC mice, which are amenable for selective eradication of p16Ink4a+ cells, 4 weeks after induction of unilateral RAS. To determine whether KIM-MSC abolish p16Ink4a -dependent cellular senescence, selective clearance of p16Ink4a+ cells was induced in a subgroup of RAS mice using AP20187 over 3 weeks prior to KIM-MSC injection. Two weeks after KIM-MSC aortic injection, renal senescence, function, and tissue damage were assessed. KIM-MSC delivery decreased gene expression of senescence and senescence-associated secretory phenotype factors, and improved micro-MRI-derived stenotic-kidney glomerular filtration rate and perfusion. Renal fibrosis and tubular injury also improved after KIM-MSC treatment. Yet, their efficacy was slightly augmented by prior elimination of p16Ink4a+ senescent cells. Therefore, selective targeting of MSC to the injured kidney markedly improves their senolytic potency in murine RAS, despite incomplete eradication of p16+ cells. KIM-MSC may constitute a useful therapeutic strategy in chronic renal ischemic injury.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University School of Medicine and Pusan National University Yangsan Hospital, Yangsan, Korea.
- Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Cardiology, Mayo Clinic, Rochester, Minnesota, USA.
- Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.
ORCID profiles: Seo Rin Kim, Lilach O Lerman
Funding
- NIDDK NIH HHS
- NIA NIH HHS
- National Institutes of Health
Cite
APA
Kim, S. R., Jiang, K., Chen, X., Puranik, A. S., Zhu, X. Y., Lerman, A., Tchkonia, T., Kirkland, J. L., & Lerman, L. O. (2022). Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage. Journal of Tissue Engineering and Regenerative Medicine, 16(6), 550-558. https://doi.org/10.1002/term.3299
Vancouver
Kim SR, Jiang K, Chen X, Puranik AS, Zhu XY, Lerman A, et al. Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(6):550-558. doi:10.1002/term.3299
BibTeX
@article{Kim2022,
author = {Kim, Seo Rin and Jiang, Kai and Chen, Xiaojun and Puranik, Amrutesh S and Zhu, Xiang-Yang and Lerman, Amir and Tchkonia, Tamara and Kirkland, James L and Lerman, Lilach O},
title = {Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage},
journal = {Journal of Tissue Engineering and Regenerative Medicine},
year = {2022},
volume = {16},
number = {6},
pages = {550--558},
doi = {10.1002/term.3299}
}
EUVIMED